Drug Discovery

Absci Corporation Secures $100 Million for Drug Discovery Innovations

Absci Corporation secured $100 million in an underwritten offering, earmarking funds to advance its lead candidate, ABS-201, for pattern hair loss and endometriosis, according to Pharmaceutical Techno